The treatment goals for systemic lupus erythematosus (SLE) are to control the overactivity of the immune system, alleviate symptoms, prevent organ damage, and reduce the frequency of flare-ups. Treatment strategies should be adjusted based on the patient's age, severity of symptoms, and affected organs, emphasizing the principle of personalized medicine. Physicians typically combine pharmacological and non-pharmacological approaches and regularly assess treatment responses to adjust plans.
The treatment process requires close collaboration between the patient and the healthcare team, with regular monitoring of blood indicators and symptom changes to ensure the safety and effectiveness of the treatment. In long-term management, reducing disease activity and improving quality of life are core objectives, while also monitoring and managing medication side effects.
Modern medical technologies provide various treatment options, but there is currently no cure. Therefore, the focus of treatment is on delaying disease progression, maintaining physiological function, and enhancing the overall health status of the patient. Patients need to understand the long-term and complex nature of the treatment and cooperate with the recommendations of professional physicians.
The treatment of systemic lupus erythematosus is divided into two main directions: control during acute flares and chronic management. During acute phases, high doses of immunosuppressants or corticosteroids may be needed to rapidly suppress the immune system, while chronic management focuses on maintaining low-dose medications and controlling symptoms. Treatment options include:
Treatment plans should be adjusted based on the affected organs; for example, patients with joint involvement may require anti-inflammatory medications, while those with kidney damage may need intensified immunosuppressive therapy. Physicians will dynamically adjust medication dosages based on assessment tools like the SLEDAI (Systemic Lupus Erythematosus Disease Activity Index).
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to relieve mild joint pain and inflammation, such as ibuprofen and naproxen. These medications can alleviate musculoskeletal symptoms but are ineffective against systemic immune abnormalities and are usually used as adjunctive medications for symptom management. Caution is needed regarding gastrointestinal irritation and cardiovascular risks when using these drugs.
Corticosteroids such as prednisone are key medications during acute flare-ups, capable of rapidly suppressing immune responses. High doses are used for severe organ damage (e.g., nephritis or neurological symptoms), while chronic management may involve long-term low-dose use. However, long-term use may lead to side effects such as osteoporosis and hypertension, necessitating calcium and vitamin D supplementation.
Immunosuppressants such as mycophenolate and cyclophosphamide are used for moderate to severe cases and can inhibit the proliferation of immune cells. These medications require regular monitoring of blood cell counts and liver and kidney function, as they may increase the risk of bone marrow suppression or infections. Newer JAK inhibitors (e.g., tofacitinib) target specific signaling pathways, providing more precise treatment options.
Hydroxychloroquine is a foundational medication for long-term treatment, alleviating skin and joint symptoms and reducing flare frequency. Its anti-inflammatory and immunomodulatory mechanisms are not fully understood, but it is considered a first-line drug for chronic management. Monitoring retinal health is necessary to avoid vision damage during use.
Biologics such as belimumab and rituximab target specific immune molecules, blocking B cell activation to suppress autoimmune responses. These targeted therapies have fewer side effects than traditional medications, but their efficacy varies among individuals, and treatment costs are higher. Other emerging targeted drugs are in clinical trial phases and may become central to future treatments.
Non-pharmacological therapies play a crucial role in overall management, especially in improving quality of life and alleviating symptoms. The main non-pharmacological options include:
NB-UVB phototherapy can alleviate skin erythema and photosensitivity symptoms, but overexposure should be avoided. Skin care should involve using high-SPF sunscreen, wearing UV-protective clothing, and avoiding direct sunlight. Topical medications such as corticosteroid creams can treat skin lesions, but local side effects should be monitored.
Physical therapy can improve joint stiffness and muscle pain, increasing joint mobility through heat therapy, ultrasound treatment, or exercise therapy. Patients with severe joint damage may require occupational therapy to restore daily functions. Regular exercise programs (e.g., aquatic exercise) can enhance physical fitness but should avoid excessive fatigue.
Chronic diseases often accompany depression and anxiety; psychological counseling and support groups can help patients cope with emotional challenges. Cognitive-behavioral therapy (CBT) has been shown to improve anxiety symptoms related to the disease. Social support systems are crucial for treatment adherence, and family involvement can enhance patient compliance with treatment.
Lifestyle adjustments are an important component of treatment, with key management strategies including:
Ultraviolet light is a key trigger for symptoms; patients should completely avoid sun exposure and use physical protective measures. Infections, stress, and certain medications (e.g., procainamide) may also trigger flare-ups and should be avoided.
An anti-inflammatory diet (e.g., Mediterranean diet) may reduce inflammatory markers. It is recommended to increase Omega-3 fatty acids to alleviate joint discomfort and reduce processed foods and high-sugar diets to lower oxidative stress. Some patients may need to supplement with vitamin D and calcium to mitigate corticosteroid side effects.
Moderate aerobic exercise (e.g., walking, swimming) can enhance cardiovascular function and immune regulation but should avoid excessive fatigue. Strength training can improve joint stability but should be conducted under the guidance of a physical therapist. Managing sleep quality is also crucial, with a recommendation of 7-8 hours of regular sleep daily to maintain immune balance.
Current research focuses on precision medicine and new targeted therapies, with the following major development directions:
1. Cell therapy: CAR-T cell therapy is in early trials, attempting to reprogram the immune system to reduce autoimmune responses.
2. Gene therapy: Exploring intervention methods for specific gene defects (e.g., Toll-like receptor abnormalities) may provide gene-modifying treatments in the future.
3. Drug reconfiguration: Developing oral biologics and long-acting injectable forms to enhance patient medication convenience and adherence.
4. Combination therapy: Combining drugs with different mechanisms to improve efficacy, such as using JAK inhibitors alongside antibody-based medications.
Monoclonal antibodies targeting specific immune molecules are in clinical trial phases; for example, drugs that block BLys protein can reduce B cell activation. Additionally, inhibitors targeting the IFN-α pathway may improve skin and joint symptoms. These drugs may reduce the side effects of traditional chemotherapy, but long-term safety requires further evaluation.
Analysis of genotypes and biomarkers can help physicians select the most appropriate medications. For instance, patients with specific HLA genotypes may respond better to certain treatments; such personalized therapies can reduce unnecessary trial medications. Future developments may lead to systems that dynamically adjust drug dosages based on patients' biological indicators.
Patients should seek immediate medical attention in the following situations: new signs of organ damage (e.g., increased protein in urine), unexplained fever lasting more than 48 hours, new neurological symptoms (e.g., seizures or cognitive impairment). The following situations require discussion with a physician to adjust treatment plans:
It is recommended to conduct a comprehensive evaluation every 3-6 months, including anti-nuclear antibodies (ANA), complement levels, and organ function tests. When symptoms worsen for unknown reasons, immediate emergency evaluation is necessary to avoid serious complications.
Immunosuppressants can indeed lower immunity and increase the risk of infections. Patients are advised to undergo regular blood tests and discuss personalized treatment plans with their physician. It is essential to maintain personal hygiene and avoid exposure to sources of infection; if fever or discomfort occurs, seek medical attention immediately.
How should daily skin care be adjusted during a lupus flare?Lupus patients' skin is often sensitive to light; during flares, they should avoid direct sunlight and use SPF 50+ sunscreen that protects against UVA/UVB when outdoors, along with wearing long-sleeved clothing and wide-brimmed hats. If the skin shows erythema or ulcers, avoid using irritating cosmetics and switch to moisturizing repair products recommended by a physician.
If pregnant during treatment, do medications need to be adjusted?Lupus patients should evaluate the stability of their condition with their physician before pregnancy; some medications, such as non-steroidal anti-inflammatory drugs, may need to be discontinued in favor of safer alternatives. During pregnancy, antibody levels and fetal conditions should be closely monitored, and the physician will adjust treatment strategies as needed to ensure maternal and fetal safety.
Are there any dietary restrictions or recommendations to pay special attention to?A low-salt, high-fiber diet rich in Omega-3 foods, such as deep-sea fish and nuts, is recommended, along with reducing processed food intake to lower inflammatory responses. Some patients may have photosensitivity related to the intake of certain chlorophyll-rich foods (e.g., lettuce), so they can record dietary and symptom correlations and discuss adjustments with their physician.
Can traditional Chinese medicine or herbal therapies be used alongside Western medicine?Traditional Chinese medicines may affect the immune system or interact with Western medications; it is essential to inform the attending physician of all traditional medicines or supplements being used. Some ingredients in traditional Chinese medicine may trigger disease activity, so integrated treatment should be assessed for safety under the supervision of both traditional Chinese and Western medicine professionals.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
